Monday 10 August 2020 12:00
Part of the Mortality and Longevity webinar series.
The working party will help the industry to update and enhance how potential risk from diabetes and excess mortality is considered, including the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes.